Daily archive

Cannabis industry news

A growing archive of sourced cannabis industry coverage across regulation, medical markets, licensing, imports, retail, and public-company developments.

Showing 31-45 of 95

Spain’s Medical-Cannabis System Appears to Reach Its First Product Registrations

Spain’s medicines agency appears to have formally registered two cannabis preparations for the hospital-pharmacy medical pathway, turning the country’s 2025 framework from a rulebook into a live supply system.

Spain’s medical-cannabis framework appears to have crossed an important line. Curaleaf said on 13 July that Spain’s medicines agency, AEMPS, formally registered two standardized cannabis preparations under Royal Decree 903/2025, with registry numbers CAN-1 and CAN-2.

Pennsylvania Dry-Leaf Wholesale Has Fallen to $2.80 a Gram as the Medical Market Keeps Expanding

Pennsylvania’s latest medical-cannabis board data show dry-leaf wholesale pricing at $2.80 per gram through May 2026 and retail at $7.49, underscoring how new cultivation and store capacity is arriving into an already cheaper flower market.

Pennsylvania’s latest official medical-cannabis data show a clear change in the economics of flower. In a June 24 program update presented to the state’s Medical Marijuana Advisory Board, the Department of Health said average wholesale pricing for dry leaf reached $2.80 per gram...

Washington’s 29% Cannabis License-Fee Increase Is Now Live for Existing Operators

Washington has put a $400 annual fee increase into effect for standard cannabis producers, processors, and retailers, raising the renewal cost to $1,781 and adding a new fixed expense for businesses that already hold licenses.

Washington has raised the annual state license fee for standard cannabis producers, processors, and retailers to $1,781 from $1,381. The increase took effect in practice on July 1, 2026, when the Washington State Liquor and Cannabis Board, the state regulator for cannabis and...

France’s medical cannabis reimbursement decree reaches legal review

France’s last missing reimbursement text for medical cannabis has been sent for legal review, a step that brings the country closer to a permanent but tightly restricted treatment market.

France’s last missing text on medical cannabis reimbursement has moved into legal review. Trade reporting says the decree was submitted to the Conseil d’État on 2026-07-02, which is the formal review stage before a French decree can be published.

Minnesota’s Adult-Use Storefront Rollout Is Still Thin, With 12 Retailer Licenses Issued Out of 150

Minnesota’s latest cannabis licensing data shows the state still has only a dozen issued adult-use retailer licenses, a slow pace that matters because the current 150-store cap will stay in place until at least mid-2027.

Twelve retailer licenses against a 150-store cap is the clearest signal in Minnesota’s new data

Kentucky’s Medical Cannabis Launch Enters a Harder Phase With 18 of 48 Dispensaries Open

Kentucky ended the state protection that had let patients rely on out-of-state medical cannabis on July 1, but only 18 of its 48 licensed dispensaries were listed as open by July 9.

Kentucky’s medical cannabis program has reached the point where paperwork matters less than doors, inventory and distance.

California Opens Comment on Mature-Plant Group Tagging Rule With $9.55 Million Savings Estimate

California regulators are taking comment on a rule that would let cannabis growers tag mature plants in groups instead of one by one, a change the state says would cut cultivation costs by $9.55 million a year while slightly lifting legal-market sales.

California is moving on a narrow cannabis cultivation rule with broad practical effects. The state’s Department of Cannabis Control is taking written comments through July 27 and will hold a public hearing on July 28 on a proposal that would let licensed growers tag mature...

GLOBALJul 8, 2026

Brazil Took Every Recorded Uruguayan Export in One Medical-Cannabis Category Last Year

Uruguay’s newly published 2025 trade tables show Brazil absorbed the country’s entire recorded export category for medical-cannabis medicines and active ingredients, underscoring how quickly a bilateral supply lane is hardening as Brazil resets its rules.

Uruguay’s 2025 export tables now show something unusually concentrated. In the country’s recorded category for medical-cannabis medicines and active pharmaceutical ingredients, or APIs, Brazil was the only destination.

Ukraine’s Medical-Cannabis Launch Now Has a Visible Product Pipeline

Ukraine has moved beyond drafting rules into real medical-cannabis access, with first legal dispensing underway and 49 product and ingredient filings already in the state registration queue.

Ukraine’s medical-cannabis rollout has crossed the line from policy to operation. On 15 June, the State Expert Center said it had received 49 registration applications for cannabis-based medicines and active pharmaceutical ingredients, or APIs, and that 13 cannabis APIs were...

Nebraska’s medical manufacturer license window is open through a live rule handoff

Nebraska is accepting manufacturer applications until July 20, but applicants are filing while the state shifts from emergency medical-cannabis rules to permanent ones during the only open business licensing window.

Nebraska’s only active medical-cannabis business application window opened on June 24 and closes on July 20 at 11:59 p.m. CDT. It lasts 27 days. During that span, the state is also changing the legal basis for the program’s operating rules.

Virginia Sets Feb. 1, May 1 and July 1 Dates for Adult-Use Cannabis Launch

Virginia’s enacted budget gives the state a real 2027 cannabis timetable, opening adult-use license applications on February 1, allowing the first licenses on May 1, and holding retail sales until July 1.

Virginia’s budget turns adult-use cannabis from a political promise into a dated launch plan

GLOBALJun 30, 2026

Argentina Opens a Temporary Licensing Bridge for Medicinal Cannabis Propagation

A new temporary licensing window gives existing seed and clone businesses in Argentina a formal way into the national medicinal-cannabis system, but it stops at propagation material and does not cover flower or extracts.

Argentina has opened a temporary national licensing route for medicinal-cannabis propagation material. The new regime was published in the Official Gazette on June 30 as Resolution 41/2026 and will take effect 10 business days later. It stays open until March 1, 2027 and is...

Spain’s Medical Cannabis Supply Base Opens With Just 14 Active Cultivation Authorizations

Spain has activated its medical-cannabis system, but the growers and manufacturers allowed to feed that channel still number only 14 active cultivation authorizations, with five of them limited to validation batches rather than routine supply.

Spain’s medical-cannabis system is now live, but the upstream supply base behind it is still unusually small. As of 2026-05-27, the Spanish Agency of Medicines and Medical Devices, known as AEMPS, listed 14 active cannabis cultivation authorizations tied to medical and...

DEA’s Broader Marijuana Schedule III Hearing Opens June 29 With Seven Outside Participants

The federal hearing will decide whether marijuana beyond already-rescheduled state medical products should move to Schedule III, fixing the timetable and the voices that will shape the record.

The next federal hearing over marijuana’s status under U.S. drug law opens Monday, June 29, and the schedule is now fixed. The Drug Enforcement Administration says the proceeding will begin at 9:00 a.m. Eastern in Arlington, Virginia, and conclude no later than July 15. It has...

Maryland Delays Medical Cannabis Delivery Handoff for One Year

A new state law keeps existing dispensaries delivering medical cannabis until July 2027, preventing a July 1 cutoff that regulators said the new micro-dispensary system could not yet handle statewide.

Maryland has delayed a forced handoff in medical-cannabis delivery. House Bill 622, now enacted as Chapter 375, extends converted dispensaries’ authority to deliver medical cannabis to patients until July 1, 2027. Under prior law, that authority was set to end on July 1, 2026.